Improving the financial condition by considering funding options
First written in FY2017-Q3. 24 of 35 entries say "Advanced", first in FY2018-Q3. Latest entry: FY2027-H1.
91 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Series 7 and Series 8 share acquisition rights issued on 15 November 2024 were exercised during the interim consolidated accounting period, increasing share capital and capital surplus by ¥94.060 million each during the period.」
Regarding Series 7 and Series 8 share acquisition rights, exercise progressed during the interim period, increasing share capital and capital surplus by ¥94.060 million each. Financing through share acquisition rights continues to progress. - FY2026AdvancedAnnual report
「This was mainly attributable to a net increase in short-term borrowings of ¥878.708 million, proceeds of ¥634.000 million from the issuance of new shares, repayments of ¥84.700 million on long-term borrowings, and repayments of ¥130.918 million on long-term accounts payable, among other factors.」
The Company raised ¥634.000 million through an increase in short-term borrowings and the issuance of new shares, bringing funds acquired through financing activities to ¥1,214.805 million. Exercise of Series 7 and Series 8 share acquisition rights is also progressing. - 2026-03-12AdvancedRevisions to earnings forecasts
「This was mainly attributable to a net increase in short-term borrowings of ¥878.708 million, proceeds of ¥634.000 million from the issuance of new shares, repayments of ¥84.700 million on long-term borrowings, and repayments of ¥130.918 million on long-term accounts payable, among other factors.」
In addition to the increase in borrowings, the company reported ¥634.000 million in proceeds from the issuance of new shares. - FY2026-H1AdvancedAnnual report
「Series 8 share acquisition rights issued on 15 November 2024 were exercised during the interim consolidated accounting period. As a result, during the interim consolidated accounting period, share capital and capital surplus each increased by ¥96.772 million,」
Regarding Series 8 share acquisition rights, 1,650,000 shares were exercised during the interim period, raising ¥188.100 million. Share capital and capital surplus also each increased by ¥96.772 million, marking progress from the issuance stage reported in the prior fiscal year to the exercise and financing stage. As of the filing date, the number of shares issued had increased further through the share delivery and additional exercise of share acquisition rights. - FY2025AdvancedAnnual report
「Proceeds from issuance of shares 149,200 Proceeds from issuance of share acquisition rights 25,236」
During the fiscal year, the Company issued 900,000 new shares through a third-party allotment and raised ¥149.200 million, and also issued Series 7 share acquisition rights representing 1,800,000 shares and Series 8 share acquisition rights representing 6,300,000 shares. The exercise period for both series is from 15 November 2024 to 13 November 2026. - FY2025-H1AdvancedAnnual report
「Through a simplified share delivery taking effect on 15 May 2024, capital surplus increased by ¥440.200 million on 15 May 2024, and stood at ¥3,452.957 million as of the end of the interim consolidated accounting period.」
In addition to the policy of considering financing methods depending on circumstances, the Company carried out a simplified share delivery in connection with making 北山商事 a subsidiary, increasing capital surplus by ¥440.200 million. It issued 6,200,000 common shares. - FY2024SoftenedAnnual report
「The Company's basic policy for working capital is to use cash flow generated from operating activities and long- and short-term borrowings from financial institutions. Depending on circumstances, it will also secure funds through direct financing.」
Instead of the prior years' results for the issuance and exercise of share acquisition rights, the Company describes a general policy of relying primarily on internal funds and borrowings, with direct financing conducted depending on circumstances. - FY2023AdvancedAnnual report
「During the fiscal year, the Company raised ¥536.119 million in the direct financing market through the disposal and exercise of Series 6 treasury share acquisition rights with exercise price adjustment clauses by third-party allotment, securing funds required for business operations while seeking to maintain liquidity.」
The Company raised ¥536.119 million through direct financing from the disposal and exercise of Series 6 treasury share acquisition rights during the fiscal year. Proceeds increased from ¥232.158 million in the prior fiscal year, indicating further progress in securing funds. - FY2023-Q3AdvancedAnnual report
「As of 31 October 2022, following the disposal of the 5,988,000 shares underlying the Company's Series 6 share acquisition rights, the exercise balances were 2,994,000 shares for 株式会社Y.S.D (fully exercised) and 2,240,100 shares for 株式会社協栄情報 (with 753,900 shares remaining unexercised).」
Regarding Series 6 share acquisition rights, the portion held by Y.S.D was fully exercised, while 2,240,100 shares of the portion held by 協栄情報 were exercised. The Company further stated that the remaining 753,900 shares were exercised in November, eliminating all unexercised rights. - FY2023-Q2AdvancedAnnual report
「In addition, based on a resolution of the Board of Directors dated 28 July 2022, the Company entered into share acquisition rights transfer agreements with 株式会社Y.S.D and 株式会社協栄情報 to dispose of the 5,988,000 shares underlying the Company's Series 6 share acquisition rights acquired on 8 November 2021, transferring 2,994,000 shares to each company. Both companies confirmed that, while appropriately balancing mutual business synergies with the Company and their pure investment objectives, they would sell the shares in the market after considering future share price movements and market trading conditions, rather than rushing to make short-term sales.」
The Company entered into an agreement to transfer 2,994,000 shares underlying the Series 6 share acquisition rights to each of Y.S.D and 協栄情報, specifying a policy of selling the shares in the market while balancing business synergies with pure investment. - FY2022AdvancedAnnual report
「During the fiscal year, the Company raised ¥232.158 million in the direct financing market through the exercise of Series 6 share acquisition rights by third-party allotment, securing funds required for business operations and seeking to maintain liquidity.」
While Series 6 share acquisition rights progressed to the acquisition of the unexercised portion, the Company raised ¥232.158 million through exercise during the fiscal year and sought to secure working capital and liquidity. - FY2022-Q3ReframedAnnual report
「However, because exercise of these share acquisition rights stagnated due to the weak share price and other factors, on 24 November 2021 the Company acquired all unexercised rights in accordance with the terms of issue. Going forward, it will consider selecting prospective transferees who are expected to exercise the rights more promptly.」
Financing through the issuance and exercise of share acquisition rights moved to the stage of acquiring all unexercised rights following stagnation in exercise caused by the weak share price and other factors. Going forward, the Company states that it will consider selecting prospective transferees expected to exercise the rights more promptly. - FY2022-Q2RestatedAnnual report
「Having determined that it was necessary to secure working capital and raise funds for investment in new businesses while implementing measures as appropriate to enhance the enterprise value of the Group, the Company carried out financing as announced in its timely disclosure dated 8 December 2020, titled "Notice Concerning the Issuance of Series 5 and Series 6 Share Acquisition Rights Through a Third-Party Allotment (with Exercise Price Adjustment Clauses)."」
The Company continues to describe financing through Series 5 and Series 6 share acquisition rights as a means of securing working capital and raising funds for investment in new businesses. - FY2022-Q1AdvancedAnnual report
「The exercise of Series 6 share acquisition rights increased share capital and capital reserves by ¥117.990 million each,」
Exercise of Series 6 share acquisition rights progressed, increasing share capital and capital reserves by ¥117.990 million each during the first quarter. Financing progressed further from the issuance resolution and the prior year's exercise results. - FY2021AdvancedAnnual report
「During the fiscal year, the Company raised ¥166.189 million in the direct financing market through the issuance and exercise of Series 6 share acquisition rights by third-party allotment, securing funds required for business operations and seeking to maintain liquidity.」
Series 6 share acquisition rights progressed from the resolution-to-issue stage to the exercise stage, and the Company raised ¥166.189 million through direct financing during the fiscal year. - FY2021-Q3AdvancedAnnual report
「At a meeting of the Company's Board of Directors held on 8 December 2020, the Company resolved to issue Series 5 share acquisition rights through a third-party allotment to its representative director, Deng Minghui (鄧明輝), and Series 6 share acquisition rights through a third-party allotment to 有限会社進栄商興.」
The Company progressed from considering financing methods to the specific implementation stage, with resolutions to issue Series 5 and Series 6 share acquisition rights. If all rights are exercised, total proceeds of approximately ¥1,100 million are expected, to be allocated to working capital, repayment of borrowings, investment in a Chinese subsidiary and funding for new businesses, among other purposes. - FY2021-Q2RestatedAnnual report
「Because the businesses described above require a certain amount of funding and the Company needs to improve its financial position, it will also consider appropriate capital policies and other measures.」
The disclosure has moved away from specific descriptions of the issuance and exercise of share acquisition rights and continues to state a policy of considering appropriate capital policies to advance the businesses and improve the Company's financial position. - FY2021-Q1SoftenedAnnual report
「Because the businesses described above require a certain amount of funding and the Company needs to improve its financial position, it will also consider appropriate capital policies and other measures.」
Instead of the specific financing details previously described, such as the issuance and exercise of share acquisition rights, this time the disclosure uses general wording stating that appropriate capital policies and other measures will be considered. - FY2020AdvancedAnnual report
「During the fiscal year, the Company raised ¥448.542 million in the direct financing market through the issuance and exercise of Series 4 share acquisition rights by third-party allotment, securing funds required for business operations and seeking to maintain liquidity.」
Series 4 share acquisition rights progressed from the issuance stage to the exercise stage, and the Company raised ¥448.542 million through direct financing during the fiscal year. At the fiscal year-end, unexercised share acquisition rights representing 1,587,000 underlying shares remained. - FY2020-Q3AdvancedAnnual report
「As exercise of these share acquisition rights subsequently progressed slowly, the Company's financial adviser introduced investors who might be willing to acquire and exercise them. As disclosed in the notices dated 31 October and 1 November 2019 concerning the transfer of Series 4 share acquisition rights, 45,670 unexercised Series 4 share acquisition rights were transferred to 有限会社SHホールディングス. By 29 November, 有限会社SHホールディングス had exercised 29,800 share acquisition rights, providing the Company with ¥363 million in funding.」
Regarding Series 4 share acquisition rights, 29,800 rights were exercised after 45,670 unexercised rights were transferred, bringing the Company to the stage of securing ¥363 million in funding. - FY2020-Q2RestatedAnnual report
「Because the Company requires a certain amount of funding to advance the businesses described above and needs to improve its financial position, the Board of Directors resolved at its meeting held on 1 April 2019 to issue Series 4 share acquisition rights through a third-party allotment. Following approval of the relevant proposal at the Company's 35th annual general meeting of shareholders held on 26 April 2019, the share acquisition rights were issued with 8 May 2019 as the allotment date.」
The Company continues to state that Series 4 share acquisition rights were issued on 8 May 2019 following approval by the Board of Directors and the general meeting of shareholders. - FY2020-Q1AdvancedAnnual report
「Because the Company requires a certain amount of funding to advance the businesses described above and needs to improve its financial position, the Board of Directors resolved at its meeting held on 1 April 2019 to issue Series 4 share acquisition rights through a third-party allotment. Following approval of the relevant proposal at the Company's 35th annual general meeting of shareholders held on 26 April 2019, payment was completed on 8 May 2019.」
Regarding Series 4 share acquisition rights, payment was completed on 8 May 2019 following approval by the Board of Directors and the general meeting of shareholders. The issue comprised 51,970 rights, with an exercise price of ¥122 per share and an exercise period from 9 May 2019 to 8 May 2021. - FY2019AdvancedAnnual report
「At a meeting of the Board of Directors held on 1 April 2019, the Company resolved to issue Series 4 share acquisition rights through a third-party allotment. Following approval of the relevant proposal at the Company's 35th annual general meeting of shareholders held on 26 April 2019, the share acquisition rights were to be issued with 8 May 2019 as the allotment date.」
Regarding the financing, the Company proceeded to the specific issuance stage, following the resolution to issue Series 4 share acquisition rights through a third-party allotment and approval at the general meeting of shareholders: 51,970 rights, 5,197,000 potential shares and proceeds of ¥645,727,250. - FY2019-Q3AdvancedAnnual report
「On 10 July 2018, the Company received payment for a third-party allotment of shares from SAMURAI&J PARTNERS株式会社. In addition, Leading Securities Co., Ltd. exercised share acquisition rights in August 2018. As a result, during the nine months ended December 2018, share capital and capital reserves each increased by ¥238.522 million, and as of the end of the third quarter, share capital was ¥1,787.432 million and capital surplus was ¥2,053.472 million.」
In addition to the third-party allotment of shares, share acquisition rights were exercised, increasing share capital and capital reserves by ¥238.522 million each. In addition, borrowing of ¥215 million secured by real estate held for sale was approved, further specifying the Company's financing methods. - FY2019-Q2AdvancedAnnual report
「On 10 July 2018, the Company received payment for a third-party allotment of shares from SAMURAI＆J PARTNERS株式会社. As a result, during the six months ended September 2018, share capital and capital reserves each increased by ¥224.927 million, and as of the end of the second quarter, share capital was ¥1,773.837 million and capital surplus was ¥2,039.877 million.」
Measures to improve the Company's financial position progressed from the implementation of a third-party allotment of shares to the specific developments of payment on 10 July 2018 and increases of ¥224.927 million each in share capital and capital reserves. - FY2018RestatedAnnual report
「On 20 June 2017, the company received a ¥30.000 million loan from DADU (HONG KONG) CO., LIMITED (大都（香港）實業有限公司), owned by the company's representative director, Deng Minghui (鄧明輝). At the time of the capital increase on 30 November 2017, the company's borrowing was applied to the capital increase proceeds through a debt-to-equity swap.」
The implementation of financing through a private placement and a debt-to-equity swap was confirmed as a full-year measure to improve the company's financial position. - FY2018-Q3AdvancedAnnual report
「At a meeting of the board of directors held on 9 November 2017, the company resolved to issue new shares through a private placement and completed a ¥249.994 million capital increase on 30 November of the same year.」
The financing plan moved from the consideration stage to implementation, with completion of a ¥249.994 million capital increase through a private placement. However, the company stated that eliminating the excess liabilities remained uncertain. - FY2018-Q1RestatedAnnual report
「The company is also considering financing options and will take early steps to improve its financial position.」
The company continued to explain that it was considering financing options as a means of improving its financial position. - FY2017RestatedAnnual report
「We are also considering financing options and examining ways to improve our financial position.」
The company continued to explain that it was considering financing options as a means of improving its financial position. - FY2017-Q3First statedAnnual report
「We are also considering financing options and examining ways to improve our financial position.」
First explicitly states that the company is considering financing methods as a means of improving its financial position.